1Pfizer R&D Japan, Tokyo, Japan
2Takeda Pharmaceutical Company Limited, Osaka, Japan
3Astellas Pharma Inc., Tokyo, Japan
4Ferring Pharmaceuticals Ltd., Kowloon, Hong Kong
5Abbott Indonesia, South Jakarta, Indonesia
6Merck Sharp & Dohme, Taipei, Taiwan
7KPBMA, Seoul, Korea
8GE Healthcare AS Korea, Seoul, Korea
9Pharmaceutical Association of Malaysia (PhAMA), Selangor, Malaysia
10Pfizer, Inc. (Philippines), Makati, Philippines
11Pfizer (Thailand) Limited, Bangkok, Thailand
12Takeda Pharmaceuticals International AG, Singapore, Singapore
13Johnson & Johnson Pte Ltd, Singapore, Singapore
14Pharma Group Vietnam, Ho Chi Minh, Vietnam
15Pfizer Limited (India), Mumbai, India
16Sanofi Global Regulatory Science & Policy, China & Asia team, Beijing, China
© The Author(s) 2022
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.